rs6559167

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BA1

The NM_001118887.2(ANGPT2):​c.408G>T​(p.Ala136Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.309 in 1,613,718 control chromosomes in the GnomAD database, including 78,299 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★). Synonymous variant affecting the same amino acid position (i.e. A136A) has been classified as Benign.

Frequency

Genomes: 𝑓 0.29 ( 6737 hom., cov: 30)
Exomes 𝑓: 0.31 ( 71562 hom. )

Consequence

ANGPT2
NM_001118887.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: -2.49

Publications

19 publications found
Variant links:
Genes affected
ANGPT2 (HGNC:485): (angiopoietin 2) This gene belongs to the angiopoietin family of growth factors. The protein encoded by this gene is an antagonist of angiopoietin 1, and both angiopoietin 1 and angiopoietin 2 are ligands for the endothelial TEK receptor tyrosine kinase. Angiopoietin 2 is upregulated in multiple inflammatory diseases and is implicated in the direct control of inflammation-related signaling pathways. The encoded protein affects angiogenesis during embryogenesis and tumorigenesis, disrupts the vascular remodeling ability of angiopoietin 1, and may induce endothelial cell apoptosis. This gene serves a prognostic biomarker for acute respiratory distress syndrome. [provided by RefSeq, Aug 2020]
MCPH1 (HGNC:6954): (microcephalin 1) This gene encodes a DNA damage response protein. The encoded protein may play a role in G2/M checkpoint arrest via maintenance of inhibitory phosphorylation of cyclin-dependent kinase 1. Mutations in this gene have been associated with primary autosomal recessive microcephaly 1 and premature chromosome condensation syndrome. Alternatively spliced transcript variants have been described. [provided by RefSeq, Feb 2010]
MCPH1 Gene-Disease associations (from GenCC):
  • microcephaly 1, primary, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • microcephaly with intellectual disability
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary breast carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 8-6532368-C-A is Benign according to our data. Variant chr8-6532368-C-A is described in ClinVar as Benign. ClinVar VariationId is 158839.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-2.49 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.388 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANGPT2NM_001118887.2 linkc.408G>T p.Ala136Ala synonymous_variant Exon 2 of 9 ENST00000629816.3 NP_001112359.1 O15123-3
MCPH1NM_024596.5 linkc.2214+32439C>A intron_variant Intron 12 of 13 ENST00000344683.10 NP_078872.3 Q8NEM0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANGPT2ENST00000629816.3 linkc.408G>T p.Ala136Ala synonymous_variant Exon 2 of 9 1 NM_001118887.2 ENSP00000486858.2 O15123-3
MCPH1ENST00000344683.10 linkc.2214+32439C>A intron_variant Intron 12 of 13 1 NM_024596.5 ENSP00000342924.5 Q8NEM0-1

Frequencies

GnomAD3 genomes
AF:
0.294
AC:
44577
AN:
151794
Hom.:
6737
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.241
Gnomad AMI
AF:
0.258
Gnomad AMR
AF:
0.288
Gnomad ASJ
AF:
0.321
Gnomad EAS
AF:
0.403
Gnomad SAS
AF:
0.235
Gnomad FIN
AF:
0.285
Gnomad MID
AF:
0.408
Gnomad NFE
AF:
0.321
Gnomad OTH
AF:
0.330
GnomAD2 exomes
AF:
0.300
AC:
75368
AN:
251380
AF XY:
0.302
show subpopulations
Gnomad AFR exome
AF:
0.241
Gnomad AMR exome
AF:
0.252
Gnomad ASJ exome
AF:
0.325
Gnomad EAS exome
AF:
0.400
Gnomad FIN exome
AF:
0.276
Gnomad NFE exome
AF:
0.323
Gnomad OTH exome
AF:
0.321
GnomAD4 exome
AF:
0.310
AC:
453601
AN:
1461806
Hom.:
71562
Cov.:
63
AF XY:
0.310
AC XY:
225351
AN XY:
727206
show subpopulations
African (AFR)
AF:
0.237
AC:
7933
AN:
33476
American (AMR)
AF:
0.262
AC:
11711
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.328
AC:
8564
AN:
26134
East Asian (EAS)
AF:
0.418
AC:
16594
AN:
39694
South Asian (SAS)
AF:
0.252
AC:
21719
AN:
86240
European-Finnish (FIN)
AF:
0.280
AC:
14946
AN:
53410
Middle Eastern (MID)
AF:
0.355
AC:
2050
AN:
5768
European-Non Finnish (NFE)
AF:
0.316
AC:
351306
AN:
1111970
Other (OTH)
AF:
0.311
AC:
18778
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
17667
35334
53000
70667
88334
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11382
22764
34146
45528
56910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.293
AC:
44580
AN:
151912
Hom.:
6737
Cov.:
30
AF XY:
0.291
AC XY:
21597
AN XY:
74236
show subpopulations
African (AFR)
AF:
0.241
AC:
9985
AN:
41408
American (AMR)
AF:
0.288
AC:
4401
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.321
AC:
1114
AN:
3466
East Asian (EAS)
AF:
0.403
AC:
2075
AN:
5152
South Asian (SAS)
AF:
0.233
AC:
1118
AN:
4804
European-Finnish (FIN)
AF:
0.285
AC:
3013
AN:
10554
Middle Eastern (MID)
AF:
0.411
AC:
120
AN:
292
European-Non Finnish (NFE)
AF:
0.321
AC:
21827
AN:
67936
Other (OTH)
AF:
0.327
AC:
692
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1593
3187
4780
6374
7967
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
464
928
1392
1856
2320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.304
Hom.:
2252
EpiCase
AF:
0.333
EpiControl
AF:
0.326

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
0.051
DANN
Benign
0.75
PhyloP100
-2.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6559167; hg19: chr8-6389889; COSMIC: COSV57337589; API